25503

    541304

    INDOUS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    INDO US BIOTECH LTD Share Price Today

    INDO US BIOTECH LTD is currently trading at ₹89.3, up by ₹1.0 from the previous close. The stock touched an intraday high of ₹90.35 and a low of ₹88.81 during the latest trading session. Over the past one year, INDO US BIOTECH LTD has delivered a loss of 42.0%, while the stock has declined 6.71% in the last one month.

    INDO US BIOTECH LTD performance

    Today’s low Today’s high
    ₹ 88.81 ₹ 90.35
    ₹ 89.15
    52 week low 52 week high
    ₹ 86.16 ₹ 206.00
    ₹ 89.15
    Open Price ₹ 90.35
    Prev. Close ₹ 88.30
    Volume (Shares) 2790.00
    Total traded value ₹ 2.48
    Upper Circuit ₹ 105.96
    Lower Circuit ₹ 70.64
    info

    Investment Returns

    Over 1 Month -6.71% Over 3 Months -17.77% Over 6 Months -25.23% Over 1 Year -42.00%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    INDO US BIOTECH LTD fundamentals


    • Market cap (Cr) 178.80
    • P/E Ratio (TTM) 13.56
    • Beta 0.97
    • Book Value / share 46.14
    • Return on equity 23.03%
    • EPS (TTM) 6.54
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.97
    info icon alternate text
    • Market cap (Cr) 177.80
    • P/E Ratio (TTM) 13.56
    • Beta 1.10
    • Book Value / share 46.14
    • Return on equity 23.03%
    • EPS (TTM) 6.54
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.97
    info icon alternate text

    INDO US BIOTECH LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 26.02
    Operating Expense 23.67
    Net Profit 1.97
    Net Profit Margin (%) 7.57
    Earnings Per Share (EPS) 0.98
    EBITDA 3.25
    Effective Tax Rate (%) 17.22
    Particulars DEC 2025 (Values in Cr)
    Revenue 22.80
    Operating Expense 19.64
    Net Profit 3.00
    Net Profit Margin (%) 13.15
    Earnings Per Share (EPS) 1.49
    EBITDA 4.15
    Effective Tax Rate (%) 5.37
    Particulars SEP 2025 (Values in Cr)
    Revenue 30.85
    Operating Expense 27.31
    Net Profit 3.45
    Net Profit Margin (%) 11.18
    Earnings Per Share (EPS) 1.72
    EBITDA 4.19
    Effective Tax Rate (%) 3.08
    Particulars JUN 2025 (Values in Cr)
    Revenue 30.77
    Operating Expense 25.95
    Net Profit 4.70
    Net Profit Margin (%) 15.27
    Earnings Per Share (EPS) 2.35
    EBITDA 5.47
    Effective Tax Rate (%) 2.48
    Particulars MAR 2025 (Values in Cr)
    Revenue 33.38
    Operating Expense 29.63
    Net Profit 3.68
    Net Profit Margin (%) 11.02
    Earnings Per Share (EPS) 1.86
    EBITDA 4.69
    Effective Tax Rate (%) 4.89
    Particulars MAR 2026 (Values in Cr)
    Revenue 110.44
    Operating Expense 96.57
    Net Profit 13.12
    Net Profit Margin (%) 11.87
    Earnings Per Share (EPS) 6.54
    EBITDA 17.06
    Effective Tax Rate (%) 5.74
    Particulars MAR 2025 (Values in Cr)
    Revenue 103.84
    Operating Expense 87.49
    Net Profit 16.27
    Net Profit Margin (%) 15.66
    Earnings Per Share (EPS) 8.11
    EBITDA 19.12
    Effective Tax Rate (%) 1.57
    Particulars MAR 2024 (Values in Cr)
    Revenue 72.84
    Operating Expense 64.36
    Net Profit 8.24
    Net Profit Margin (%) 11.31
    Earnings Per Share (EPS) 4.11
    EBITDA 11.10
    Effective Tax Rate (%) 6.25
    Particulars MAR 2023 (Values in Cr)
    Revenue 61.74
    Operating Expense 54.37
    Net Profit 7.24
    Net Profit Margin (%) 11.72
    Earnings Per Share (EPS) 7.51
    EBITDA 9.40
    Effective Tax Rate (%) 2.02
    Particulars MAR 2022 (Values in Cr)
    Revenue 50.05
    Operating Expense 44.75
    Net Profit 5.27
    Net Profit Margin (%) 10.52
    Earnings Per Share (EPS) 5.75
    EBITDA 7.11
    Effective Tax Rate (%) 4.00
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 42.01
    ROE % 16.91
    ROCE % 15.11
    Total Debt to Total Equity 0.41
    EBITDA Margin 13.92
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 35.17
    ROE % 25.94
    ROCE % 17.20
    Total Debt to Total Equity 0.53
    EBITDA Margin 13.41
    Particulars MAR 2020 (Values in Cr)
    Book Value / Share 27.10
    ROE % 15.39
    ROCE % 14.56
    Total Debt to Total Equity 0.52
    EBITDA Margin 9.98
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 39.16
    ROE % 23.03
    ROCE % 21.13
    Total Debt to Total Equity 0.21
    EBITDA Margin 18.41
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 31.29
    ROE % 14.06
    ROCE % 14.30
    Total Debt to Total Equity 0.22
    EBITDA Margin 15.25
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 54.35
    ROE % 15.51
    ROCE % 14.37
    Total Debt to Total Equity 0.26
    EBITDA Margin 15.24
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 42.41
    ROE % 17.35
    ROCE % 15.50
    Total Debt to Total Equity 0.40
    EBITDA Margin 14.25
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 35.50
    ROE % 26.86
    ROCE % 17.85
    Total Debt to Total Equity 0.53
    EBITDA Margin 13.89
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 55.61
    Total Liabilities 55.61
    Total Equity 38.50
    Share Outstanding 0
    Price to Book Ratio 1.59
    Return on Assets (%) 9.10
    Return on Capital (%) 9.86
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.13
    Total Assets 43.70
    Total Liabilities 43.70
    Total Equity 21.34
    Share Outstanding 0
    Price to Book Ratio 0.92
    Return on Assets (%) 11.21
    Return on Capital (%) 14.89
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 0.20
    Total Assets 34.69
    Total Liabilities 34.69
    Total Equity 16.44
    Share Outstanding 0
    Price to Book Ratio 1.89
    Return on Assets (%) 7.30
    Return on Capital (%) 10.43
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.24
    Total Assets 97.84
    Total Liabilities 97.84
    Total Equity 78.51
    Share Outstanding 2
    Price to Book Ratio 3.76
    Return on Assets (%) 16.62
    Return on Capital (%) 17.43
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.09
    Total Assets 84.45
    Total Liabilities 84.45
    Total Equity 62.74
    Share Outstanding 2
    Price to Book Ratio 7.09
    Return on Assets (%) 9.75
    Return on Capital (%) 10.69
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.18
    Total Assets 69.46
    Total Liabilities 69.46
    Total Equity 54.49
    Share Outstanding 1
    Price to Book Ratio 3.91
    Return on Assets (%) 10.42
    Return on Capital (%) 10.95
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 55.57
    Total Liabilities 55.57
    Total Equity 38.87
    Share Outstanding 0
    Price to Book Ratio 1.59
    Return on Assets (%) 9.42
    Return on Capital (%) 10.19
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.13
    Total Assets 43.67
    Total Liabilities 43.67
    Total Equity 21.54
    Share Outstanding 0
    Price to Book Ratio 0.92
    Return on Assets (%) 11.67
    Return on Capital (%) 15.44
    Particulars MAR 2022 (Values in Cr)
    Net Income 5.31
    Cash from Operations 3.08
    Cash from Investing -5.44
    Cash from Financing 2.65
    Net change in Cash -0.08
    Free Cash Flow 7.05
    Particulars MAR 2021 (Values in Cr)
    Net Income 3.92
    Cash from Operations 0.29
    Cash from Investing -1.77
    Cash from Financing 1.55
    Net change in Cash -0.06
    Free Cash Flow 2.24
    Particulars MAR 2020 (Values in Cr)
    Net Income 2.86
    Cash from Operations -0.81
    Cash from Investing -0.56
    Cash from Financing 1.52
    Net change in Cash 0.11
    Free Cash Flow -0.41
    Particulars MAR 2025 (Values in Cr)
    Net Income 16.53
    Cash from Operations 1.77
    Cash from Investing -0.79
    Cash from Financing -1.47
    Net change in Cash -0.85
    Free Cash Flow 2.63
    Particulars MAR 2024 (Values in Cr)
    Net Income 8.79
    Cash from Operations 2.53
    Cash from Investing -2.52
    Cash from Financing 1.21
    Net change in Cash 0.90
    Free Cash Flow 5.14
    Particulars MAR 2023 (Values in Cr)
    Net Income 7.38
    Cash from Operations 0.84
    Cash from Investing -6.67
    Cash from Financing 6.28
    Net change in Cash 0.14
    Free Cash Flow 2.66
    Particulars MAR 2022 (Values in Cr)
    Net Income 5.48
    Cash from Operations 3.29
    Cash from Investing -5.40
    Cash from Financing 2.41
    Net change in Cash -0.08
    Free Cash Flow 7.26
    Particulars MAR 2021 (Values in Cr)
    Net Income 4.12
    Cash from Operations 0.36
    Cash from Investing -1.75
    Cash from Financing 1.46
    Net change in Cash -0.06
    Free Cash Flow 2.27
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD 5374.40 51.10 25.35 129452.26 5038.00 6336.95
    NESTLE INDIA LIMITED 1459.40 82.69 54.57 281418.19 1085.00 1498.60
    FOODS & INNS LTD. 62.99 16.71 0.81 463.18 45.00 121.55
    HINDUSTAN UNILEVER LTD. 2200.75 33.96 10.60 517086.30 2023.05 2734.31
    MILKFOOD LTD. 71.78 0.00 1.08 183.73 43.99 87.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    BRITANNIA INDUSTRIES LTD 5374.40 50.54 27.89 129452.26 5038.00 6336.95
    COLGATE PALMOLIVE LTD. 2043.55 41.37 35.08 55581.62 1781.60 2505.00
    NESTLE INDIA LIMITED 1459.40 81.62 53.00 281418.19 1085.00 1498.60
    FOODS & INNS LTD. 62.99 14.79 0.80 463.18 45.00 121.55

    INDO US BIOTECH LTD shareholding pattern

    Holding
    31.53%
    68.29%
    0.17%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    INDO US BIOTECH LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    89.15 0.96 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 88.80
    • 26 Days 92.70
    • 10 Days 89.40
    • 50 Days 97.30
    • 12 Days 89.70
    • 100 Days 105.30
    • 20 Days 91.40
    • 200 Days 122.40
    88.55 PIVOT
    First Support 87.14 First Resistance 89.71 Second Support 85.98 Second Resistance 91.12 Third Support 84.57 Third Resistance 92.28
    RSI 38.38 ADX 39.76 MACD -2.92 Williams % R -66.96 Commodity Channel Index (CCI) -65.37
    Date 2026-07-03 Week 15696.00 Same Day 2010.00 Month 19004.00
    1 Year 0.97 3 Year 0.97
    Over 1 Month
    -6.71% down
    Over 1 Year
    -42.00% down
    Over 3 Months
    -17.77% down
    Over 3 Years
    0.00% down
    Over 6 Months
    -25.23% down
    Over 5 Years
    0.00% down

    INDO US BIOTECH LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    03 Dec 2024 0.25 Interim 03 Dec 2024 Equity shares
    28 Oct 2021 0.25 Interim 29 Oct 2021 Equity shares
    Ex-Date Ex-Bonus Ratio
    29 Aug 2023 29 Aug 2023 1:1
    30 Nov 2021 29 Nov 2021 1:5
    24 Apr 2019 23 Apr 2019 1:4
    Dividend date Dividend amount Dividend type Record date Instrument type
    03 Dec 2024 0.25 Interim 03 Dec 2024 Equity shares
    28 Oct 2021 0.25 Interim 29 Oct 2021 Equity shares
    Ex-Date Ex-Bonus Ratio
    29 Aug 2023 29 Aug 2023 1:1
    30 Nov 2021 29 Nov 2021 1:5
    24 Apr 2019 23 Apr 2019 1:4

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Indo US Bio-Tech Ltd?

    Answer Field

    Indo US Bio-Tech Ltd share price is for NSE ₹ 89.30 & for BSE ₹ 88.67 as on Jul 03 2026 03:29 PM.

    What is the Market Cap of Indo US Bio-Tech Ltd Share?

    Answer Field

    The market cap of Indo US Bio-Tech Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 03 2026 03:29 PM.

    What is the 52 Week High and Low of Indo US Bio-Tech Ltd?

    Answer Field

    The 52 Week High and Low of Indo US Bio-Tech Ltd for NSE is ₹ 206.00 and ₹ 86.16 and for BSE is ₹ 205.10 and ₹ 86.00.

    What is 1 year return for Indo US Bio-Tech Ltd?

    Answer Field

    The 1 year returns on the stock has been -42.00%.

    What is the P/E Ratio of Indo US Bio-Tech Ltd Share?

    Answer Field

    As on Jul 03 2026 03:29 PM the price-to-earnings (PE) ratio for Indo US Bio-Tech Ltd share is 13.56.

    What is the PB ratio of Indo US Bio-Tech Ltd Share?

    Answer Field

    As on Jul 03 2026 03:29 PM, the price-to-book (PB) ratio for Indo US Bio-Tech Ltd share is 46.14.

    How to Buy Indo US Bio-Tech Ltd Share?

    Answer Field

    You can trade in Indo US Bio-Tech Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Indo US Bio-Tech Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Indo US Bio-Tech Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Indo US Bio-Tech Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |